Excited to be at the Africa Health Business conference in 🇿🇦 on behalf of Wellcome, with Diogo Martins Looking forward to meeting with everyone and building new partnerships! 🌍

Deaths caused by tuberculosis are on the rise. While some recent vaccine developments are promising, progress has been slow, and the tuberculosis health crisis is escalating. Here’s what you need to know ⤵️ wellcome.org/news/tuberculo…

Great panel on an enabling environment for local production of vaccines, therapeutics and diagnostics in Africa 🌍Africa Health Business Great job by our consultant! Rachelle Harris

Pleased to share our article published in International Health on innovations in lab testing approaches to oversee Africa's local production of medical product. Read more here academic.oup.com/inthealth/adva… Mimi Darko Davidmukanga Wellcome Diogo Martins

📢The Good Clinical Trials Collaborative & #clinicaltrials networks in alliance to promote best practices for #RCTs in low resource settings! #GoodTrialsPrism seeks to enhance evidence quality in Latin America, Southeast Asia & South Africa by applying the principles of good trials goodtrials.org/the-collaborat…

🚨 Call for abstracts 6th Biennial Scientific Conference on Medical Products Regulation in Africa (SCoMRA VI) Deadline: 2 October 2023 +info: nepad.org/event/6th-bien…

🚨 Reminder: deadline approaching soon 👇🏻 5⃣ Days AUDA-NEPAD NEPAD_AMRH WHO African Region chimwemwe chamdimba Dr Divya Shah Anthony Kapeta Djamila Reis Boitumelo Mokgatla Mwemezi ngemera Johnpaul Omollo #SCOMRA

I am honoured and very excited about being selected as CEO of Wellcome. I feel privileged to be able to work with Wellcome colleagues to bring discovery science and challenge driven science to society to build a healthier future wellcome.org/news/wellcome-…

Swiss, Singapore and Korean Regulatory Agencies Become First to Receive New WHO Listing healthpolicy-watch.news/swiss-singapor…

Today, the World Health Organization (WHO) released its annual report on the state of tuberculosis (TB). The topline? TB is still one of the world's deadliest infectious diseases — and the funding needed to change that is falling well short. But there's been some promising progress... [1/5]🧵⤵️

In partnership with CEPI, we're funding research teams to establish or validate correlates of protection across 11 diseases. 💰 Level: Up to £5 million per project 💡 Duration: Up to 3 years 🗓 Preliminary application deadline: 6 Feb 2024 This is why... ⤵️ [1/5]

🇪🇬 Commencing the 6th SCoMRA in Cairo, a dynamic forum amplifying the pulse of medical product regulation in Africa. Expecting deep dives into challenges, innovation sparks, and game-changing dialogues. #SCoMRA2023

🚨 Launching today! We’ve partnered with Mediaplanet UKIE on today’s Clinical Trials campaign, launching online and within The New Scientist Read more here 👉 bitly.ws/34Hkb #ClinicalTrialsCampaign

Regulatory Collaboration Can Strengthen Medicines Access - African Scientific Conference healthpolicy-watch.news/regulatory-col…

Being part of a #BSIcommittee is a rewarding experience that offers #networking & #ProfessionalDevelopment opportunities 🚀 Interested & want to learn more? Here are some summaries about what our committees do ⤵ Nominate yourself by Fri 1 Mar 🔗bit.ly/47TgTT6 🧵 1/7

Have you ever considered joining a #BSIcommittee? Nominations are now open! 👇🏽

Wishing all the amazing #WomenInImmunology a great #InternationalWomensDay! We want to celebrate women's contributions to #immunology by shining a spotlight on the diverse & inspiring careers of some of our #BSIcommittee members 🤩 Read their profiles 👉bit.ly/49yHN4a

Great opportunity to work with a great Wellcome team on regulatory pathways and systems! Read more 👇🏽

'Fifth of medicines in Africa may be sub-par or fake, research finds' via The Guardian theguardian.com/world/article/…